Recurrent Histiocytic and Dendritic Cell Neoplasm

Explore clinical trials studying Recurrent Histiocytic and Dendritic Cell Neoplasm. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Histiocytic and Dendritic Cell Neoplasm trial results

Recruiting

NCT05786924

Conditions: Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations: Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States

The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California, San Francisco (UCSF) San Francisco, California, United States

View all 27 locations

Completed

NCT04640779

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

Active, Not Recruiting

NCT03698994

Conditions: Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +83 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 107 locations

Active, Not Recruiting

NCT04320888

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +85 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 174 locations